{
    "eid": "2-s2.0-85140169861",
    "title": "The interleukin-6/interleukin-23/T helper 17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: A precision nomothetic psychiatry analysis",
    "cover-date": "2022-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Hussein Kadhem Al-Hakeim",
        "Ali Fattah Al-Musawi",
        "Abbas Al-Mulla",
        "Arafat Hussein Al-Dujaili",
        "Monojit Debnath",
        "Michael Maes"
    ],
    "citedby-count": 5,
    "ref-count": 122,
    "ref-list": [
        "Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses",
        "False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes",
        "Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning",
        "Deficit schizophrenia: an update",
        "In (deficit) schizophrenia, a general cognitive decline partly mediates the effects of neuro-immune and neuro-oxidative toxicity on the symptomatome and quality of life",
        "Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways",
        "In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde",
        "Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia",
        "How to construct a bottom-up nomothetic network model and disclose novel nosological classes by integrating risk resilience and adverse outcome pathways with the phenome of schizophrenia",
        "The macrophage-T-lymphocyte theory of schizophrenia: additional evidence",
        "Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond",
        "Inflammation in schizophrenia",
        "Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment",
        "Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment",
        "Cytokine alterations in schizophrenia: an updated review",
        "The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia",
        "The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study",
        "Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis",
        "High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments",
        "Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis",
        "First Episode Psychosis and Schizophrenia Are Systemic Neuro-Immune Disorders Triggered by a Biotic Stimulus in Individuals with Reduced Immune Regulation and Neuroprotection",
        "Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia",
        "A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions",
        "In schizophrenia, non-remitters and partial remitters to treatment with antipsychotics are qualitatively distinct classes with respect to neurocognitive deficits and neuro-immune biomarkers: results of soft independent modeling of class analogy",
        "The role of Th17 cells in auto-inflammatory neurological disorders",
        "Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications",
        "Proinflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine",
        "Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia",
        "Essential autocrine regulation by IL-21 in the generation of inflammatory T cells",
        "Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia",
        "Activation of Th17 cells in drug na\u00efve, first episode schizophrenia",
        "Th17 cell differentiation: the long and winding road",
        "IL-17 and Th17 Cells",
        "IL-23 drives a pathogenic T cell population that induces autoimmune inflammation",
        "The Th17 Lineage: From Barrier Surfaces Homeostasis to Autoimmunity, Cancer, and HIV-1 Pathogenesis",
        "MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation",
        "Curcumin inhibiting Th17 cell differentiation by regulating the metabotropic glutamate receptor-4 expression on dendritic cells",
        "The TNF/IL-23/IL-17 axis\u2014Head-to-head trials comparing different biologics in psoriasis treatment",
        "IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells",
        "The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells",
        "Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia",
        "Zinc in schizophrenia: A meta-analysis",
        "Magnesium in schizophrenia",
        "Calcium signaling dysfunction in schizophrenia: a unifying approach",
        "Association between decreased serum albumin levels and depressive symptoms in patients with schizophrenia in a Chinese Han population: A pilot study",
        "The schedule for the deficit syndrome: an instrument for research in schizophrenia",
        "The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations",
        "A pattern probability model for the classification of psychiatric patients",
        "A rating scale for depression",
        "The assessment of anxiety states by rating",
        "Eotaxin, an endogenous cognitive deteriorating chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients",
        "The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery",
        "Controlling the false discovery rate in behavior genetics research",
        "Structural equation modeling with the SmartPLS",
        "Aberrations in the Cross-Talks Among Redox, Nuclear Factor-\u03baB and Wnt/Catenin Pathway Signaling Underpin Myalgic Encephalomyelitis andChronic Fatigue Syndrome: A Review and New Hypothesis Based on Results of Network, Enrichment and Annotation Analyses",
        "Lowered antioxidant defenses and increased oxidative toxicity are hallmarks of deficit schizophrenia: a nomothetic network psychiatry approach",
        "Increased levels of plasma tumor necrosis factor-\u03b1 mediate schizophrenia symptom dimensions and neurocognitive impairments and are inversely associated with natural IgM directed to malondialdehyde and paraoxonase 1 activity",
        "Natural regulatory IgM-mediated autoimmune responses directed against malondialdehyde regulate oxidative and nitrosative pathways and coupled with IgM responses to nitroso adducts attenuate depressive and physiosomatic symptoms at the end of term pregnancy",
        "Elevated serum interleukin-23 and interleukin-6 levels in schizophrenic patients compared to those in healthy controls",
        "Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia",
        "Increased interleukin 23 (IL23) levels in schizophrenia patients treated with depot antipsychotic medication",
        "Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study",
        "Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway",
        "Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases",
        "Risk-based high-throughput chemical screening and prioritization using exposure models and in vitro bioactivity assays",
        "IL-23/IL-17/G-CSF pathway is associated with granulocyte recruitment to the lung during African swine fever",
        "The IL-23/IL-17 axis in inflammation",
        "TGF-\u03b2 and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell\u2013mediated pathology",
        "Stat3 and Stat4 direct development of IL-17-secreting Th cells",
        "Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation",
        "Interleukin-23: a key cytokine in inflammatory diseases",
        "Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides",
        "TH-17 cells in the circle of immunity and autoimmunity",
        "Exploring the role of interleukin-22 in neurological and autoimmune disorders",
        "Impact of interleukin-21 in the pathogenesis of primary Sjogren\u2019s syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands",
        "Interleukin-21: a double-edged sword with therapeutic potential",
        "Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target",
        "The TNF/IL-23/IL-17 axis\u2014Head-to-head trials comparing different biologics in psoriasis treatment",
        "Relationship of Brain-Derived Neurotrophic Factor with Interleukin-23, Testosterone and Disease Severity in Schizophrenia",
        "The Protein-Protein Interaction Network of First Episode Psychosis and Schizophrenia Reveals Possible Trigger Factors and New Drug Targets among Intracellular Signal Transduction Pathways and Neurotoxicity Processes",
        "Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs",
        "Complement component C4 levels in the cerebrospinal fluid and plasma of patients with schizophrenia",
        "Regulatory effects of C5a on IL-17A, IL-17F, and IL-23",
        "Human TH 17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation",
        "Cellular mechanisms of IL-17induced blood-brain barrier disruption",
        "Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia",
        "Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development",
        "IL-22: there is a gap in our knowledge",
        "Interleukin-23 increases intestinal epithelial cell permeability in vitro",
        "IL-23 and Th17 cytokines in intestinal homeostasis",
        "Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability",
        "IL-22 signaling contributes to West Nile encephalitis pathogenesis",
        "Cytokines IL-17 and IL-22 in the host response to infection",
        "IL-21 mediates microRNA-423-5p /claudin-5 signal pathway and intestinal barrier function in inflammatory bowel disease",
        "In Schizophrenia, Increased Plasma IgM/ IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype",
        "Towards a new classification of stable phase schizophrenia into major and simple neuro-cognitive psychosis: Results of unsupervised machine learning analysis",
        "Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?",
        "Production and functions of IL-17 in microglia",
        "CNS-specific synthesis of interleukin 23 induces a progressive cerebellar ataxia and the accumulation of both T and B cells in the brain: characterization of a novel transgenic mouse model",
        "Interleukin-17 inhibits adult hippocampal neurogenesis",
        "IL-21 stokes brain inflammation",
        "The Roles of IL-22 and Its Receptor in the Regulation of Inflammatory Responses in the Brain",
        "Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes",
        "Neuroprotective effects of IL-22 during CNS inflammation",
        "IL-22 induces an acute-phase response",
        "Impairments in peripheral blood T effector and T regulatory lymphocytes in bipolar disorder are associated with staging of illness and anti-cytomegalovirus IgG levels",
        "Association between Serum Essential Metal Elements and the Risk of Schizophrenia in China",
        "In vitro findings of alterations in intracellular calcium homeostasis in schizophrenia",
        "Association of Elements with Schizophrenia and Intervention of Selenium Supplements",
        "Serum and cerebrospinal levels of calcium and magnesium in acute versus remitted schizophrenic patients",
        "Plasma magnesium levels in a population of psychiatric patients: correlations with symptoms",
        "Comparing Copper Serum Level and Cognitive Functioning in Patients With Schizophrenia and Healthy Controls",
        "Estimation of serum zinc and copper levels patients with schizophrenia: a preliminary study",
        "A brief note on serum calcium levels in schizophrenics and controls",
        "Vitamin D, parathyroid hormone, serum calcium and phosphorus in patients with schizophrenia and major depression",
        "Magnesium, schizophrenia and manic-depressive disease",
        "A pathway phenotype linking metabolic, immune, oxidative, and opioid pathways with comorbid depression, atherosclerosis, and unstable angina",
        "Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness",
        "Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims",
        "Zinc in the Glutamatergic Theory of Depression",
        "A functional interaction of sodium and calcium in the regulation of NMDA receptor activity by remote NMDA receptors",
        "Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders"
    ],
    "affiliation": [
        {
            "affiliation-city": "Kufa",
            "@id": "60071160",
            "affilname": "University of Kufa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071160",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Najaf",
            "@id": "60109789",
            "affilname": "The Islamic University, Najaf",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60109789",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bengaluru",
            "@id": "60016175",
            "affilname": "National Institute of Mental Health and Neuro Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016175",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kufa",
            "@id": "128755615",
            "affilname": "University of AL-Kafeel",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128755615",
            "affiliation-country": "Iraq"
        }
    ],
    "funding": []
}